ustransplant Home | Contact us | Site Map
About the SRTRExpand About the SRTR
|
National Transplant StatisticsExpand National Transplant Statistics
|
Program and OPO DataExpand Program and OPO Data
|
Research ResourcesExpand Research Resources
Publication Details

CITATION:
Luan FL, Steffick DE, Ojo AO. Steroid-free maintenance immunosuppression in kidney transplantation: Is it time to consider it as a standard therapy? Kidney International, in press.

Click for the article in PubMed Go to PubMed links
ABSTRACT:
Steroid-free immunosuppression in kidney transplantation has been gaining popularity over the past decade, as documented by a continuous and steady rise in the number of kidney transplant patients discharged on steroid-free regimens. This increased interest in steroid-free immunosuppression is fueled by the recognition that half of transplant loss is related to patient death due to cardiovascular disease and/or infectious complications and that the long-term use of steroids contributes to such elevated cardiovascular morbidity and mortality. The availability of newer and more potent immunosuppressive agents has furthered such interest. Many clinical trials over the past two decades have demonstrated the feasibility of steroid-free regimens, at the expense of a slight increase in the rate of acute rejection, which is an important end point in any clinical trial of relatively short duration. The largest epidemiological study to date has reassured the transplant community that the selective use of steroid-free immunosuppression in kidney transplant patients provides no inferior outcome in patient and graft survival at intermediate term. Steroid-free regimens have the potential to improve cardiovascular risk profile. The challenges that remain are to identify the subset of kidney transplant patients who may not benefit from steroid-free immunosuppression and to demonstrate the survival advantage of steroid-free immunosuppresion in suitable kidney transplant candidates.

Information for Patients and Families Information for Transplant Community and Policy Makers Information for Researchers
Spacer Choose an audience
Transplant Program and OPO Specific Data
Fast Facts give an overview of recent waiting list and transplant activity


Contact the SRTR

315 W. Huron St.
Suite 360
Ann Arbor, MI 48103 USA
Tel: +1 (800) 830-9664
Fax: +1 (734) 665-2103
Email Us

The SRTR is administered by the Arbor Research Collaborative for Health with the University of Michigan,
with oversight and funding from the Health Resources and Services Administration.

About the SRTR | National Transplant Statistics | Program and OPO Data | Research Resources | Privacy Statement 		Spacer
Spacer